ALZAMEND NEURO, INC. (ALZN)

SEC filing

ALZAMEND NEURO, INC.

ALZN · CIK 1677077

4/A · Aug 20, 2026 · Director, Other Ault Capital Group was granted 7,500 Series D Convertible Preferred Stock at $1,000.00/unit ($7.5M)

4/A

Director, Other Ault Capital Group was granted 7,500 Series D Convertible Preferred Stock at $1,000.00/unit ($7.5M)

PRIMARY DOCUMENT

xslF345X06/marketforms-73837.xmlSEC.gov

Graphics and non-inline formats (not embedded below).